NVCT Nuvectis Pharma posts slight Q4 2025 EPS miss yet shares edge higher on positive investor sentiment ALIS Calisa CEO lays out 2024 regional expansion priorities alongside latest quarterly earnings release BNC CEA Indus shares climb 941 percent following the release of its Q3 2023 earnings results